Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8592279rdf:typepubmed:Citationlld:pubmed
pubmed-article:8592279lifeskim:mentionsumls-concept:C0040616lld:lifeskim
pubmed-article:8592279lifeskim:mentionsumls-concept:C0011209lld:lifeskim
pubmed-article:8592279lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:8592279lifeskim:mentionsumls-concept:C0020591lld:lifeskim
pubmed-article:8592279lifeskim:mentionsumls-concept:C0020028lld:lifeskim
pubmed-article:8592279lifeskim:mentionsumls-concept:C0009830lld:lifeskim
pubmed-article:8592279lifeskim:mentionsumls-concept:C0332173lld:lifeskim
pubmed-article:8592279lifeskim:mentionsumls-concept:C0205099lld:lifeskim
pubmed-article:8592279lifeskim:mentionsumls-concept:C1709269lld:lifeskim
pubmed-article:8592279pubmed:issue6lld:pubmed
pubmed-article:8592279pubmed:dateCreated1996-4-4lld:pubmed
pubmed-article:8592279pubmed:abstractTextFor public health concerns, a nominal daily delivery of anxiolytic and hypnotic drugs has progressively been set up since March 1992 for the whole of the North University-Hospital Center (U.H.C) of Marseille. The purpose of this monitored prescription process is to limit their use, which seemed undue. After the first six month of implementation, drug use decreased significantly(-50%) and has since stabilized. This reduction is particularly pronounced for benzodiazepines and especially anxiolytic drugs. The decree of August 9, 1991 has enabled us to optimize the delivery of these drugs and thus improve prescription for more rational indications.lld:pubmed
pubmed-article:8592279pubmed:languagefrelld:pubmed
pubmed-article:8592279pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8592279pubmed:citationSubsetIMlld:pubmed
pubmed-article:8592279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8592279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8592279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8592279pubmed:statusMEDLINElld:pubmed
pubmed-article:8592279pubmed:issn0047-2166lld:pubmed
pubmed-article:8592279pubmed:authorpubmed-author:BalansardGGlld:pubmed
pubmed-article:8592279pubmed:authorpubmed-author:Bues-CharbitM...lld:pubmed
pubmed-article:8592279pubmed:authorpubmed-author:JentileBBlld:pubmed
pubmed-article:8592279pubmed:authorpubmed-author:Amirat-Combra...lld:pubmed
pubmed-article:8592279pubmed:issnTypePrintlld:pubmed
pubmed-article:8592279pubmed:volume50lld:pubmed
pubmed-article:8592279pubmed:ownerNLMlld:pubmed
pubmed-article:8592279pubmed:authorsCompleteYlld:pubmed
pubmed-article:8592279pubmed:pagination489-93lld:pubmed
pubmed-article:8592279pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:8592279pubmed:meshHeadingpubmed-meshheading:8592279-...lld:pubmed
pubmed-article:8592279pubmed:meshHeadingpubmed-meshheading:8592279-...lld:pubmed
pubmed-article:8592279pubmed:meshHeadingpubmed-meshheading:8592279-...lld:pubmed
pubmed-article:8592279pubmed:meshHeadingpubmed-meshheading:8592279-...lld:pubmed
pubmed-article:8592279pubmed:meshHeadingpubmed-meshheading:8592279-...lld:pubmed
pubmed-article:8592279pubmed:meshHeadingpubmed-meshheading:8592279-...lld:pubmed
pubmed-article:8592279pubmed:meshHeadingpubmed-meshheading:8592279-...lld:pubmed
pubmed-article:8592279pubmed:articleTitle[Hypnotics and anxiolytics: nominal daily delivery and development of their consumption at North University Hospital Center of Marseille (1991-1994)].lld:pubmed
pubmed-article:8592279pubmed:affiliationService Pharmacie, Hôpital Nord (A.P Marseille), France.lld:pubmed
pubmed-article:8592279pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8592279pubmed:publicationTypeEnglish Abstractlld:pubmed